Organogenesis Provides Update on Second Phase 3 ReNu® Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/5/2026

1. SPCX
2. AMD
3. DOX
4. BKNG
5. ANET
6. PINS
7. HNGE
8. TOST
9. SNDK
10. WDC

Go back to Organogenesis Provides Update on Second Phase 3 ReNu® Study
(NASDAQ: ORGO) Delayed: 2.37 --0 (-0%)
Previous Close $2.37    52 Week High $ 
Open $2.38    52 Week Low $ 
Day High $2.40    P/E N/A 
Day Low $2.32    EPS $ 
Volume 660,799